UOC
HLGN

UBS O'Connor’s Heliogen, Inc. HLGN Stock Holding History

UBS O'Connor’s Portfolio HLGN Stock Details HLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,808
Closed -$2.37M – 1058
2021
Q3 		$2.37M Sell
6,808
-1,769
-21% -$613K 0.02% 526
2021
Q2 		$2.91M Buy
+8,577
New +$2.92M 0.03% 397

Other funds holding HLGN

PML
Prime Movers Lab Jackson, Wyoming $13.5M AUM 0% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
NC
NZS Capital Denver, Colorado $3B AUM 21.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS O'Connor's HLGN Position: Q4 2021 in Review

UBS O'Connor sold out of Heliogen, Inc. (HLGN) in Q4 2021, closing a stake of 6,808 shares — an estimated $2.37M sold.

UBS O'Connor first reported a position in HLGN in Q2 2021 and held it in 2 quarters. The position peaked at $2.91M in Q2 2021. 25 funds tracked by Wall St. Rank hold HLGN as of Q4 2021.

  • UBS O'Connor reported no remaining Heliogen, Inc. position as of Q4 2021 after selling out during the quarter.
  • UBS O'Connor sold 6,808 Heliogen, Inc. shares in Q4 2021, an estimated $2.37M.
  • UBS O'Connor first reported a position in Heliogen, Inc. in Q2 2021 and held it in 2 quarters.
  • UBS O'Connor's Heliogen, Inc. position peaked at $2.91M in Q2 2021.
  • 25 funds tracked by Wall St. Rank held Heliogen, Inc. as of Q4 2021.

Based on UBS O'Connor's 13F filing for Q4 2021, filed 14 Feb 2022.